Strategic partnerships made during global virtual conference will result in millions of dollars

To Sum Up

Plenty of businesses met their new partners. Photo by Luis Alvarez/Getty

Earlier in August, participants from around the globe gathered online for HealthTech Beyond Borders, a virtual summit hosted by ProChile that's designed to match American and Chilean businesses looking to explore the future and impact of new technologies in the healthcare sector.

During the four-day event, registrants sat in on more than 65 meetings — or an average of 2.5 meetings per hour — that tackled such topics as "Why Chile? Exploring Chilean Medical Innovations," "Dynamic Growth for Healthcare Innovators/Innovations (Venture Capital)," and "Harnessing Healthcare's Regional Resources: Chicago, Houston, Philadelphia."

"I was really impressed by the quality of groups and speakers for this event," says Torrey Adams, senior director of global life sciences at Greater Houston Partnership. "It was a very well put together with excellent networking and connecting opportunities. I gained a much better insight on the possibilities of collaborating with Chilean companies."

There were 37 registrants from Texas, which also contributed such strategic partners as Houston Methodist Hospital, the City of Houston, Houston Exponential, The Cannon, Greater Houston Partnership, MediaTech Ventures, Central Houston Inc., and InnovationMap (hello!).

A total of 35 Chilean companies participated, with such heavy-hitters as Cens (the national center for healthcare systems), ChileTech (a health providers association), Apis (medical devices), and CNL (the national labs board) joining the roster.

"It was a pleasure to moderate the HealthTech Beyond Borders session," says José F. Núñez, vice president of global development at Houston Methodist Global Health Care Services. "It is forums like these that foster the exchange of ideas and bring together individuals and organizations to further promote innovation in the health sciences space. Kudos to ProChile, Chicago, Houston, and Philadelphia for the resources they provide to entrepreneurs in facilitating these connections."

Though it's impossible to know the actual numbers — ProChile isn't privy to private negotiations — a survey taken by the attending companies estimates that $1 million in immediate business will be done as a direct result of the event. In the next 12 months, that figure is estimated to jump up to $2.9 million.

"We created an inclusive 'village' of innovation where entrepreneurs and startups from around the world come to solve humankind's boldest challenges," says Robert Pieroni, director of economic development for Central Houston, Inc. "Events like ProChile's HeathTech Beyond Borders demonstrate how the world is responding to what Houston has built. With Downtown Launchpad, TMC Innovation, the Ion, and others, we are clearly becoming a global center of gravity to inspire innovation and support entrepreneurship."

Find your next global match. Photo by Tone Fotografia/Getty

Final call for virtual global healthtech summit — and it's free to attend

Get Your Tickets

It's nearly time: The online international summit HealthTech Beyond Borders is about to explore the future and impact of new technologies in the healthcare sector. A special focus on medical and healthcare developments and opportunities in Chicago, Houston, and Philadelphia is the highlight this year's event.

The basics
HealthTech Beyond Borders is sponsored by ProChile and runs August 10-13, with four days of virtual programming. You can reserve your spot for free here.

The topics
A curated group of successful Chilean and U.S. healthtech companies are participating, including those that specialize in artificial intelligence, 3-D printing, medical robotics, gene therapies, nanomedicine, neurotechnology, eye care tech, telehealth, imaging diagnostics, wellness and fitness, mental health, and more.

The summits
There are three summits on the docket., each beginning at 9:55 am Central. Day one's focus is "Why Chile? Exploring Chilean Medical Inventions," while day two will cover "Dynamic Growth for Healthcare Innovators/Innovations." Day three's focus is "Harnessing Healthcare's Regional Resources: Chicago, Houston, Philadelphia."

The speakers
Panelists include Matias Gutierrez, CEO of Genosur LLC; Alberto Rodríguez Navarro from Levita Magnetics, and such Chilean organizations as Asocciación de Clínicas, Asociación de Proveedores de la Industria de la Salud, Associación Nano Cámara Nacional de Laboratorios, ChileTec, Cobre, and Hospital Fundación Lopez Perez.

From the United States, presenting organizations include MEDIATECH Ventures, Houston Methodist, MATTER Health, the Chilean & American Chamber of Commerce of Greater Philadelphia, City of Houston, City of Philadelphia, Greater Houston Partnership, The Cannon, World Business Chicago, and Widener University Small Business Development Council.

The stats
A whopping 13 percent of Chile's startups are healthcare related (according to the Science, Technology, Knowledge, and Innovation Ministry of Chile) and the growth rate of robotic surgeries done in Chile between 2010 and 2018 increased by 674 percent.

An estimated 93.7 percent of the Chilean population is covered by health insurance, and the county has one of the highest shares of health spending in relation to its gross domestic product (GDP) in Latin America.

Likewise, the United States is the top destination for Chilean exports of medical devices, representing over 25 percent of the total Chilean exports in the sector.

The Free Trade Agreement of 2004 and the Duty-Free status between the two countries also make Chile an attractive and reliable trade partner. So much so, that the U.S. is the No. 1 investor in Chile, with $22 billion invested in projects in the last 7 years.

You won't want to miss this virtual gathering — RSVP for free here.

Connect globally without ever leaving the States. Photo by Leo Patrizi/Getty

It's almost time for the free global healthtech event you won't want to miss

Reserve Your Spot

Imagine a gathering of such healthtech heavy-hitters as Genosur, Levita, MEDIATECH Ventures, Houston Methodist, and MATTER Health, all in one (virtual) room.

Now imagine hearing not only from these companies, but from a dozen more representing both America and Chile in a four-day online event, held August 10-13 that's free to attend.

HealthTech Beyond Borders, sponsored by ProChile, helps facilitate matchmaking opportunities between medical and healthcare organizations from both countries. Not only can they learn from one another, but hopefully these meetings will set the stage for future global collaborations.

The international summit will also explore the future and impact of new technologies in the healthcare sector. A special focus on medical and healthcare developments and opportunities in Chicago, Houston, and Philadelphia is the highlight this year's event.

"We are proud to produce this event and bring so many innovative and leading healthcare organizations and associations together," says Sylas Bailey-Kelly, Chilean Trade Commissioner US Midwest. "Medical and healthcare innovation is an area where Chile and the United States can excel and continue to collaborate to benefit citizens in both countries, and around the world."

As the top investor in Chile, with $22 billion devoted to Chilean projects in the last seven years, the United States is the largest stakeholder in Chilean business developments and the top destination for Chilean exports of medical devices.

Likewise, an estimated 93.7 percent of the population in Chile is covered by health insurance, and the country has one of the highest shares of health spending in relation to its gross domestic product (GDP) in Latin America. Chile currently spends nearly 9.14 percent of its GDP on health as compared to the United States, where we only spend 13 percent on healthcare.

Some helpful logistics about the event: Its matchmaking platform allows participants to customize meeting times to fit their own schedules. Attendees can pick and choose which days and times they want to attend and can have one-to-one meetings (25 minutes per meeting) with Chilean participants from research centers, universities, hospitals, healthcare solution providers, and other key Chilean institutions.

The schedule for panel discussions will be posted in advance of the meeting. Presentations on partnering with Chile and the economic opportunities available, along with conversations on geographic hot spots in the U.S. and access to capital, will also be topics highlighted throughout the event.

A more detailed list of the participants includes Chilean organizations Asocciación de Clínicas, Asociación de Proveedores de la Industria de la Salud, Associación Nano Cámara Nacional de Laboratorios, ChileTec, Cobre, and Hospital Fundación Lopez Perez. From the United States, presenting organizations include the Chilean & American Chamber of Commerce of Greater Philadelphia, City of Houston, City of Philadelphia, Greater Houston Partnership, The Cannon, World Business Chicago, and Widener University Small Business Development Council.

If your company develops and sells healthcare products and services, medical devices, and equipment, or is a hospital supply manufacturer, you should attend this unique event.

Registration for HealthTech Beyond Borders is free — reserve your spot now.

Connect globally for free. Photo by AJ Watt/Getty

Get a glimpse at the schedule and speakers for global healthtech event

Itinerary Time

HealthTech Beyond Borders is coming up August 10-13, 2021, where American healthtech companies can find their perfect match with Chilean collaborators. But what exactly can you expect from the free, virtual event?

Besides answering the question "why Chile?," the seminars will touch on everything from software solutions and medical facility management to healthcare products and services, and even venture capital opportunities.

A curated group of successful Chilean and U.S. healthtech companies are participating, including those that specialize in artificial intelligence, 3-D printing, medical robotics, gene therapies, nanomedicine, neurotechnology, eye care tech, telehealth, imaging diagnostics, wellness and fitness, mental health, and more.

The first day includes such panelists as Matias Gutierrez, CEO of Genosur LLC, and Alberto Rodríguez Navarro from Levita Magnetics.

A discussion on the current healthcare innovation ecosystem in Chile and the region's strengths, as well as developments for key sub-sectors are also on tap.

Day two kicks off with everything you'd want to know about venture capital, and why the U.S. has been the largest for Chilean startups.

Find answers to questions like what do early stage companies need to consider and what steps do they need to take to best prepare themselves to receive funding, as well as what are the important tools for companies to reach VC on each territory?

Day three examines the question "Why the U.S.?" What have Houston, Chicago, and Philadelphia done to become key healthcare hubs in the world, and what role do international partners play in these efforts? Representatives from each city are participating.

Likewise, why do international healthcare companies prioritize your respective markets, and how do these cities support expansion? Learn how the global U.S. private healthcare sector can reach Latin America, and how ProChile — the event's sponsor — can help make these connections.

Registration is now open, so get your free tickets here.

Great collaboration doesn't abide by borders. Photo by Blue Images/Getty

Free virtual event helps healthtech companies go global

Matchmaker, Matchmaker

In the growing healthtech sector, two is better than one — two partners, that is. If you've ever been curious what collaborating with an international company would be like, HealthTech Beyond Borders can provide answers.

The free virtual event, sponsored by ProChile and set for August 10-13, 2021, was created to offer matchmaking opportunities and set the scene for global collaborations focused on innovative medical technology between companies from Chile and the United States.

A curated group of successful Chilean and U.S. healthtech companies are participating, including those that specialize in artificial intelligence, 3-D printing, medical robotics, gene therapies, nanomedicine, neurotechnology, eye care tech, telehealth, imaging diagnostics, wellness and fitness, mental health, and more.

You can explore everything from software solutions and medical facility management to healthcare products and services, and even venture capital opportunities.

And if you're wondering "why Chile?" there are some pretty compelling stats.

A whopping 13 percent of Chile's startups are healthcare related (according to the Science, Technology, Knowledge, and Innovation Ministry of Chile) and the growth rate of robotic surgeries done in Chile between 2010 and 2018 increased by 674 percent.

An estimated 93.7 percent of the Chilean population is covered by health insurance, and the county has one of the highest shares of health spending in relation to its gross domestic product (GDP) in Latin America.

Likewise, the United States is the top destination for Chilean exports of medical devices, representing over 25 percent of the total Chilean exports in the sector.

The Free Trade Agreement of 2004 and the Duty-Free status between the two countries also make Chile an attractive and reliable trade partner. So much so, that the U.S. is the No. 1 investor in Chile, with $22 billion invested in projects in the last 7 years.

And with Houston being home to the largest hospital center in the world — Texas Medical Center, which served 13 million patients in 2020 — it only makes sense that healthtech companies here would be looking for ways to improve and expand. Reserve your free spot for the event here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

How Houston's innovation sector fared in 2025 Texas legislative session

That's a Wrap

The Greater Houston Partnership is touting a number of victories during the recently concluded Texas legislative session that will or could benefit the Houston area. They range from billions of dollars for dementia research to millions of dollars for energy projects.

“These wins were only possible through deep collaboration, among our coalition partners, elected officials, business and community leaders, and the engaged members of the Partnership,” according to a partnership blog post. “Together, we’ve demonstrated how a united voice for Houston helps drive results that benefit all Texans.”

In terms of business innovation, legislators carved out $715 million for nuclear, semiconductor, and other economic development projects, and a potential $1 billion pool of tax incentives through 2029 to support research-and-development projects. The partnership said these investments “position Houston and Texas for long-term growth.”

Dementia institute

One of the biggest legislative wins cited by the Greater Houston Partnership was passage of legislation sponsored by Sen. Joan Huffman, a Houston Republican, to provide $3 billion in funding over 10 years for the Dementia Prevention and Research Institute of Texas. Voters will be asked in November to vote on a ballot initiative that would set aside $3 billion for the new institute.

The dementia institute would be structured much like the Cancer Prevention and Research Institute of Texas (CPRIT), a state agency that provides funding for cancer research in the Lone Star State. Since its founding in 2008, CPRIT has awarded nearly $3.9 billion in research grants.

“By establishing the Dementia Prevention and Research Institute of Texas, we are positioning our state to lead the charge against one of the most devastating health challenges of our time,” Huffman said. “With $3 billion in funding over the next decade, we will drive critical research, develop new strategies for prevention and treatment, and support our healthcare community. Now, it’s up to voters to ensure this initiative moves forward.”

More than 500,000 Texans suffer from some form of dementia, including Alzheimer’s disease, according to Lt. Gov. Dan Patrick.

“With a steadfast commitment, Texas has the potential to become a world leader in combating [dementia] through the search for effective treatments and, ultimately, a cure,” Patrick said.

Funding for education

In the K-12 sector, lawmakers earmarked an extra $195 million for Houston ISD, $126.7 million for Cypress-Fairbanks ISD, $103.1 million for Katy ISD, $80.6 million for Fort Bend ISD, and $61 million for Aldine ISD, the partnership said.

In higher education, legislators allocated:

     
  • $1.17 billion for the University of Houston College of Medicine, University of Texas Health Science Center at Houston, UT MD Anderson Cancer Center, and Baylor College of Medicine
  • $922 million for the University of Houston System
  • $167 million for Texas Southern University
  • $10 million for the Center for Biotechnology at San Jacinto College.

Infrastructure

In the infrastructure arena, state lawmakers:

     
  • Approved $265 million for Houston-area water and flood mitigation projects, including $100 million for the Lynchburg Pump Station
  • Created the Lake Houston Dredging and Maintenance District
  • Established a fund for the Gulf Coast Protection District to supply $550 million for projects to make the coastline and ship channel more resilient

"Nuclear power renaissance"

House Bill 14 (HB 14) aims to lead a “nuclear power renaissance in the United States,” according to Texas Gov. Greg Abbott’s office. HB 14 establishes the Texas Advanced Nuclear Energy Office, and allocates $350 million for nuclear development and deployment. Two nuclear power plants currently operate in Texas, generating 10 percent of the energy that feeds the Electric Reliability Council Texas (ERCOT) power grid.

“This initiative will also strengthen Texas’ nuclear manufacturing capacity, rebuild a domestic fuel cycle supply chain, and train the future nuclear workforce,” Abbott said in a news release earlier this year.

One of the beneficiaries of Texas’ nuclear push could be Washington, D.C.-based Last Energy, which plans to build 30 micro-nuclear reactors near Abilene to serve power-gobbling data centers across the state. Houston-based Pelican Energy Partners also might be able to take advantage of the legislation after raising a $450 million fund to invest in companies that supply nuclear energy services and equipment.

Reed Clay, president of the Texas Nuclear Alliance, called this legislation “the most important nuclear development program of any state.”

“It is a giant leap forward for Texas and the United States, whose nuclear program was all but dead for decades,” said Clay. “With the passage of HB 14 and associated legislation, Texas is now positioned to lead a nuclear renaissance that is rightly seen as imperative for the energy security and national security of the United States.”

---

A version of this article first appeared on EnergyCapitalHTX.com.

View All Listings